COVID-19: Pfizer-BioNTech vaccine deliveries could begin Dec.
Pfizer Inc and BioNTech could secure emergency U.S. and European authorization for their COVID-19 vaccine next month after final trial results showed it had a 95% success rate and no…
Pfizer to begin pilot delivery program for its COVID-19 vaccine in four U.S. states
Pfizer Inc has launched a pilot delivery program for its experimental COVID-19 vaccine in four U.S. states, as the U.S. drugmaker seeks to address distribution challenges facing its ultra-cold storage…
Moderna says its experimental vaccine is 94.5% effective in preventing COVID-19
Moderna Inc said on Monday its experimental vaccine was 94.5% effective in preventing COVID-19 based on interim data from a late-stage clinical trial, becoming the second U.S. company in a…
COVID-19: WHO says vaccine safety top priority, as AstraZeneca pauses study
Safety of a prospective vaccine for COVID-19 comes “first and foremost”, the World Health Organization’s chief scientist said on Wednesday, as a trial of a candidate from AstraZeneca was paused,…
US States told to be ready to distribute COVID-19 vaccine Nov 1
The Trump administration has urged US states to get ready to distribute a potential COVID-19 vaccine by November 1 — two days before the presidential election. Dallas-based wholesaler McKesson Corp….
COVID-19: Moderna in talks with countries for vaccine supply deals
Moderna Inc said on Wednesday it has started talks with several countries for supply agreements for its experimental coronavirus vaccine and has received about $400 million in deposits for potential…
Coronavirus: Australia begins pre-clinical testing for vaccine
Australia’s national science agency said on Thursday it has commenced the first stage of testing potential vaccines for COVID-19, as it joins a global race to halt the coronavirus…